Does early (treatment in) BENEFIT lead to late MS benefit?
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published August 10, 2016.
Article Versions
- Previous version (August 10, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Brian C. Healy, PhD and
- Brian G. Weinshenker, MD
- Brian C. Healy, PhD and
Member of Biogen Worldwide Medical Biostatistics MS Advisory Board
NONE
NONE
Statistical Methods in Medical Research, editorial board, 2008-Present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Merck Serono, 12/2009-Present Novartis, 10/2012-9/2015 Genzyme, 8/2014-7/2015 Google Life Sciences, 9/2015-Present
NIH, 1UH2TR000890-01, Statistician, 2013-Present NIH, 1R01HL113272-02, Statistician, 2013-Present NIH, 1UL1TR001102-07, Statistician, 2013-Present
NONE
National Multiple Sclerosis Society
NONE
NONE
NONE
NONE
NONE
NONE
- Brian G. Weinshenker, MD
(1) Novartis data safety monitoring board member (2) Biogen Idec data safety monitoring board member (3) Mitsubishi Pharmaceuticals data safety monitoring board member
NONE
NONE
1. Canadian Journal of Neurological Sciences, editorial board member, 2006-present; no compensation 2. Turkish Journal of Neurology, editorial board member, 2005-present; no compensation 3. Neurology, editorial board member, 2014-present; no compensation
1) NMO-IgG for diagnosis of neuromyelitis optica; application 20050112116; patent issued and technology licensed to R.S.R. Ltd. and Oxford University
NONE
NONE
(1) Chugai Pharmaceuticals
NONE
(1)Medimmune Pharmaceuticals, Adjudication Committee Member
NONE
NONE
NONE
NONE
Guthy Jackson Charitable Foundation, sponsor of research in NMO, 10/2008-09/2011
NONE
NONE
NMO-IgG for diagnosis of neuromyelitis optica; patent issued and technology licensed to R.S.R. Ltd. and to Oxford University
NONE
NONE
NONE
- From the Partners Multiple Sclerosis Center (B.C.H.), Brigham and Women's Hospital, Boston; Biostatistics Center (B.C.H.), Massachusetts General Hospital, Boston; and Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN.
- Correspondence to Dr. Healy: bchealy{at}partners.org
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan